Agios Pharmaceuticals Target Price

Where could AGIO trade next? Consensus target price: $47.

Get informed when a big investor buys or sells

+ Follow

Share Price

$33.64

Average Target Price

$46.80

39.1% upside

5 analysts in the last 4 months

High: $55 | Low: $32

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-07-30	H.C. Wainwright	$55	63.5% upside
2026-07-21	H.C. WainwrightEmily Bodnar	$52	54.6% upside
2026-07-07	Truist Financial	$41	21.9% upside
2026-07-07	RBC Capital	$32	4.9% downside
2026-06-15	H.C. WainwrightEmily Bodnar	$54	60.5% upside
2026-04-30	Truist Financial	$36	7% upside
2026-04-20	H.C. WainwrightEmily Bodnar	$50	48.6% upside
2026-02-12	Truist FinancialGreg Renza	$39	15.9% upside
2025-12-26	Leerink Partners	$40	18.9% upside
2025-12-24	H.C. Wainwright	$62	84.3% upside
2025-12-24	Truist FinancialGregory Renza	$38	13% upside
2025-11-24	Truist Financial	$32	4.9% downside
2025-11-20	Goldman Sachs	$25	25.7% downside
2025-11-20	Leerink Partners	$34	1.1% upside
2025-10-20	H.C. WainwrightEmily Bodnar	$56	66.5% upside
2025-05-02	ScotiabankGreg Harrison	$71	111.1% upside
2024-10-31	Raymond JamesDanielle Brill	$51	51.6% upside
2024-09-27	Leerink PartnersAndrew Berens	$56	66.5% upside
2024-09-10	Raymond JamesChris Raymond	$56	66.5% upside
2024-06-17	Raymond JamesChris Raymond	$55	63.5% upside
2024-06-03	RBC CapitalGregory Renza	$53	57.6% upside
2024-05-28	Raymond JamesChris Raymond	$45	33.8% upside
2023-02-03	Piper Sandler	$41	21.9% upside
2022-12-01	J.P. Morgan	$33	1.9% downside
2022-11-17	Goldman Sachs	$32	4.9% downside
2021-04-30	BarclaysPeter Lawson	$70	108.1% upside

Agios Pharmaceuticals (AGIO) FAQ

The latest target price for AGIO is $47. Investors often review this figure alongside Agios Pharmaceuticals's historical trend and sector peers before judging valuation or financial health.

Agios Pharmaceuticals trades near $33.64 while the consensus target sits at $47 (39.1% upside). Targets are estimates based on earnings forecasts and valuation models; they change when analysts update ratings or revise models. Compare the average with the high and low targets for a fuller picture.

After noting AGIO's target price ($47), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Agios Pharmaceuticals's target price against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.